TickerFactsScreenerDevelopers

GT Biopharma, Inc. (GTBP) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$1.53M2011: -$963.0K2012: -$987.0K2013: -$442.0K2014: -$1.75M2015: -$4.66M2016: -$1.93M2017: -$5.43M2018: -$10.68M2019: -$3.66M2020: -$7.26M2021: -$15.61M2022: -$15.22M2023: -$8.85M2024: -$12.90M2025: -$12.91M-$12.91M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$12.91M-0.1%
2024-$12.90M-45.8%
2023-$8.85M+41.8%
2022-$15.22M+2.5%
2021-$15.61M-114.9%
2020-$7.26M-98.5%
2019-$3.66M+65.7%
2018-$10.68M-96.6%
2017-$5.43M-181.3%
2016-$1.93M+58.6%
2015-$4.66M-166.3%
2014-$1.75M-295.7%
2013-$442.0K+55.2%
2012-$987.0K-2.5%
2011-$963.0K+37.3%
2010-$1.53M—